DK0751144T3 - Nye antracyclin-pro-drugs, fremgangsmåde til fremstilling deraf samt antitumorsammensætninger og et komponentkit indeholdende disse pro-drugs - Google Patents

Nye antracyclin-pro-drugs, fremgangsmåde til fremstilling deraf samt antitumorsammensætninger og et komponentkit indeholdende disse pro-drugs

Info

Publication number
DK0751144T3
DK0751144T3 DK95201747T DK95201747T DK0751144T3 DK 0751144 T3 DK0751144 T3 DK 0751144T3 DK 95201747 T DK95201747 T DK 95201747T DK 95201747 T DK95201747 T DK 95201747T DK 0751144 T3 DK0751144 T3 DK 0751144T3
Authority
DK
Denmark
Prior art keywords
pro
drugs
processes
preparation
kit containing
Prior art date
Application number
DK95201747T
Other languages
English (en)
Inventor
Ruben Gerardus George Leenders
Eric Wilhelmus Petrus Damen
Johan Wilhelm Scheeren
Hidde Jacob Haisma
Pieter Herman Johannes Houba
Vos Dick De
Original Assignee
Pharmachemie Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie Bv filed Critical Pharmachemie Bv
Application granted granted Critical
Publication of DK0751144T3 publication Critical patent/DK0751144T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95201747T 1995-06-27 1995-06-27 Nye antracyclin-pro-drugs, fremgangsmåde til fremstilling deraf samt antitumorsammensætninger og et komponentkit indeholdende disse pro-drugs DK0751144T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201747A EP0751144B1 (en) 1995-06-27 1995-06-27 Novel anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy

Publications (1)

Publication Number Publication Date
DK0751144T3 true DK0751144T3 (da) 2004-12-27

Family

ID=8220425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95201747T DK0751144T3 (da) 1995-06-27 1995-06-27 Nye antracyclin-pro-drugs, fremgangsmåde til fremstilling deraf samt antitumorsammensætninger og et komponentkit indeholdende disse pro-drugs

Country Status (9)

Country Link
US (1) US5710135A (da)
EP (1) EP0751144B1 (da)
JP (1) JPH0912591A (da)
AT (1) ATE278700T1 (da)
CA (1) CA2178684A1 (da)
DE (1) DE69533615T2 (da)
DK (1) DK0751144T3 (da)
ES (1) ES2227536T3 (da)
PT (1) PT751144E (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
JP4465109B2 (ja) 1997-12-17 2010-05-19 エンゾン ファーマシューティカルズ,インコーポレーテッド アミノ及びヒドロキシル含有生物活性剤のポリマープロドラッグ
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6624142B2 (en) 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US6214330B1 (en) 1998-07-13 2001-04-10 Enzon, Inc. Coumarin and related aromatic-based polymeric prodrugs
US6043367A (en) * 1998-09-30 2000-03-28 Roffler; Steve Proactive antitumor compounds
JP2004518776A (ja) * 2000-12-01 2004-06-24 エンゾン,インコーポレーテッド テトラパルテートプロドラッグ
ATE378342T1 (de) * 2001-02-20 2007-11-15 Enzon Inc Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate
NZ531408A (en) * 2001-08-14 2005-07-29 Valderm Aps Topical formulation comprising a lipophilic anthracycline for the treatment of neoplastic or preneoplastic processes of a body surface
US20040038904A1 (en) * 2002-05-21 2004-02-26 Angela Ogden Method of treating multiple sclerosis
MX337052B (es) 2002-07-15 2016-02-11 Univ Texas Peptidos que se enlazan a fosfatidiletanolamina y sus usos en el tratamiento de infecciones virales y del cancer.
BRPI0820298A8 (pt) 2007-11-09 2018-05-08 Affitech Res As composições e métodos de anticorpos anti-vegf
EP2098533A1 (en) * 2008-03-07 2009-09-09 Pharmachemie B.V. Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins PROLONGED DELIVERY OF THERAPEUTIC AGENTS TO AN OCULAR COMPARTMENT
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CN104936620B (zh) 2012-01-19 2019-08-09 约翰霍普金斯大学 增强粘膜渗透的纳米粒子调配物
EP2825207B1 (en) 2012-03-16 2020-08-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
CN104363924B (zh) 2012-03-16 2018-04-17 约翰霍普金斯大学 用于递送hif‑1抑制剂的控制释放调配物
CA2872519C (en) 2012-05-04 2017-09-05 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US9533068B2 (en) 2012-05-04 2017-01-03 The Johns Hopkins University Drug loaded microfiber sutures for ophthalmic application
CN103910875B (zh) * 2012-12-31 2017-06-13 张雅珍 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
WO2016123125A1 (en) 2015-01-27 2016-08-04 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048041A3 (en) * 1978-03-27 1982-08-04 Discovision Associates Method and apparatus for writing a signal-information track by using a radiation beam
DE4002888A1 (de) 1990-02-01 1991-08-08 Behringwerke Ag Anthracyclin-glycosyl-prodrugs, verfahren zu ihrer herstellung und ihre verwendung in kombination mit funktionalisierten tumorspezifischen enzymkonjugaten
FR2676058B1 (fr) * 1991-04-30 1994-02-25 Hoechst Lab Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ES2227536T3 (es) 2005-04-01
ATE278700T1 (de) 2004-10-15
US5710135A (en) 1998-01-20
JPH0912591A (ja) 1997-01-14
EP0751144B1 (en) 2004-10-06
CA2178684A1 (en) 1996-12-28
DE69533615D1 (de) 2004-11-11
EP0751144A1 (en) 1997-01-02
DE69533615T2 (de) 2005-10-13
PT751144E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
DK0751144T3 (da) Nye antracyclin-pro-drugs, fremgangsmåde til fremstilling deraf samt antitumorsammensætninger og et komponentkit indeholdende disse pro-drugs
WO2000006771A3 (en) Nucleic acid labeling compounds
AU7433891A (en) Electrochemiluminescent assays
AU678814B2 (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
DE69432035D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
NO162080C (no) Fruktosyltransferase og anvendelse av denne til fremstilling av et fruktosid.
DE69637747D1 (de) Zuckerverbindungen
FI925988A0 (fi) Foerfarande foer framstaellning av b-laktamer
Poitout et al. Synthesis of sugar-like amino-carboxylic acids from D-mannitol
IL111184A0 (en) Inclusion complex
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
NO933817L (no) Nye 2-sakkarinylmetylarylkarboksylater som er nyttige som inhibitorer for proteolytiske enzymer, samt preparater og anvendelse
DK0401138T3 (da) Ny antibiotisk anticancerforbindelse og fremstillingen og anvendelser heraf
OKAMI et al. Ribocitrin, a new inhibitor of dextransucrase
DE3888066T2 (de) Saccharid-Derivate.
DE3881862T2 (de) Disaccharidderivate.
MA20852A1 (fr) Composes nouveaux et leurs preparations.
WO1997020855A3 (en) Solid phase organic synthesis
NO810778L (no) Homositronsyre oligoriboside-derivater, fremgangsmaate for deres fremstilling og deres bruk for aa forebygge dental karries
ATE14125T1 (de) 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro-2oxo-1h-imidazol-4-carbonsaeure-derivate.
DK0717047T3 (da) Fremgangsmåde til fremstilling af disaccharider og hidtil ukendte disaccharider
NO854909L (no) Antracyklinderivater, en mikrobiologisk fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel.
DK0883342T3 (da) Sammensætning og fremgangsmåde til at fremme planteproduktion og/eller til eliminering af ugunstige miljømæssige påvirkninger i forbindelse med plantedyrkning
ATE113608T1 (de) Antibiotikum.
DK0955310T3 (da) Hidtil ukendte (3,4,7,8,9,10)-hexahydro-6,10-dioxo-6H-pyridazino[1,2-a][1,2]diazepin-1-carboxylsyrederivater, fremgangsmåde til fremstilling af disse og anvendelse af disse til fremstilling af lægemidler